Chong Kun Dang Pharmaceutical Corp.

Active trials

• phase2A First-in-Human Study of CKD-703 in Advanced Solid Tumors and Non-Small Cell Lung Cancerrecruitingn=140
• phase1Study of CKD-215 and D215 in Adults With BRCA-mutated Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancernot yet recruitingn=24
• phase4MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipientscompletedn=158
• phase4Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.completedn=128
• phase4Efficacy and Safety of Everolimus Versus Mycophenolate Mofetil in Liver Transplant Recipients.completedn=150
• phase2Initial Pilot Study to Evaluate the Safety and Temporary Symptom Improvement Efficacy of CKD-981completedn=100
• phase1A Drug-drug Interaction Study to Investigate the Pharmacokinetic Interactions Between CKD-508, Midazolam, and Rosuvastatin in Healthy Adult Male Participantscompletedn=24
• phase1A Study to Investigate the Safety, Tolerability, PK, and PD of CKD-508 in Healthy Participantscompletedn=44